Royalty Pharma Patents – Key Insights and Stats

Royalty Pharma has a total of 211 patents globally, out of which 135 have been granted. Of these 211 patents, more than 36% patents are active. Thailand is where Royalty Pharma has filed the maximum number of patents, followed by Europe and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Royalty Pharma.

Royalty Pharma was founded in the year 1996. The Company acquires biopharmaceutical royalties. The Company funds innovation directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties and indirectly when it acquires existing royalties from the original innovators. As of April 2023, the market cap of Royalty Pharma is $16.2 Billion.

Do read about some of the most popular patents of Royalty Pharma which have been covered by us in this article and also you can find Royalty Pharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Royalty Pharma patent portfolio.

How many patents does the founder and the CEO of Royalty Pharma have?

The founder and CEO Pablo Legoretta has 0 patent.

How many patents does Royalty Pharma have?

Royalty Pharma has a total of 211 patents globally. These patents belong to 49 unique patent families. Out of 211 patents, 76 patents are active.

How Many Patents did Royalty Pharma File Every Year?

Royalty Pharma Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantRoyalty Pharma Applications FiledRoyalty Pharma Patents Granted
20222
20216
202017
201926
201813
2017213
2016314
2015312
20141316
20131418
201246
2011166

How many Royalty Pharma patents are Alive/Dead?

Royalty Pharma Patent Portfolio

 How Many Patents did Royalty Pharma File in Different Countries?

Royalty Pharma Worldwide Patent Filing

Countries in which Royalty Pharma Filed Patents

CountryPatents
Thailand20
Europe16
Japan15
Hong Kong (S.A.R.)14
United States Of America14
Denmark11
Spain9
Slovenia8
Germany7
Croatia7
Portugal6
Cyprus6
Canada5
Brazil5
Lithuania5
Korea (South)5
Luxembourg5
Australia4
Mexico4
Israel4
Viet Nam4
Indonesia4
Singapore3
Chile3
Gulf Cooperation Council3
Poland3
China2
New Zealand2
Albania2
Norway2
South Africa2
Taiwan1
Hungary1
Brunei1
Eurasia1
Turkey1
Russia1
Argentina1
Finland1
Serbia1
India1
Czech Republic1

Where are Research Centres of Royalty Pharma Patents Located?

R&D Center of Royalty Pharma

 10 Best Royalty Pharma Patents

US20040209915A1 is the most popular patent in the Royalty Pharma portfolio. It has received 169 citations so far from companies like Theravance, Glaxo Group Limited and Zentiva.

Below is the list of 10 most cited patents of Royalty Pharma:

Publication NumberCitation Count
US20040209915A1169
US20040209860A1164
US7109205B243
US6559338B133
US6677465B215
US7119097B213
US20100216800A12
JP4787184B22
JP4512105B22
JP4512106B22

What are Royalty Pharma key innovation segments?

What Technologies are Covered by Royalty Pharma?

The chart below distributes patents filed by Royalty Pharma in different countries on the basis of the technology protected in patents. It also represents the markets where Royalty Pharma thinks it’s important to protect particular technology inventions.

R&D Focus: How has Royalty Pharma search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Royalty Pharma?

Was this article helpful?

Leave a Comment

Table of Content

Popular Topics

Insights you may find interesting